#Canada #Toronto #Perimeter Medical #Imaging AI #Cancer Technologies

Perimeter Medical Imaging AI Participates in Toronto Showcase

Perimeter Medical Imaging AI, Inc., also known as Perimeter, is set to take part in the prestigious Planet MicroCap Showcase, scheduled for October 22, 2025. In an effort to enhance investor engagement, CEO Adrian Mendes will deliver a significant presentation, offering insights into the company's current commercial strategies and future milestones.

The Planet MicroCap Showcase is an essential gathering that brings together investors, analysts, and innovative public companies to explore the latest opportunities in the microcap space. This two-day event will include a mixture of presentations, networking opportunities, and thought-leadership panels, all focused on fostering investment in the small-cap sector.

Mendes's presentation will not only cover the strategic direction of Perimeter but also delve into the advancements the company is making in the field of cancer surgery. At the core of its offerings is the revolutionary Perimeter S-Series Optical Coherence Tomography (OCT) system. This FDA-cleared device provides ultra-high-resolution, real-time imaging, allowing for in-depth visualization of excised tissues at the cellular level. As cancer treatments evolve, the importance of precise imaging technology becomes more crucial in ensuring effective surgical outcomes.

The company is also thrilled to announce its investigational Perimeter B-Series OCT system, which features the ImgAssist AI technology. This next-generation tool had recently undergone assessments in pivotal clinical trials and has garnered significant support, including a grant of up to $7.4 million from the Cancer Prevention and Research Institute of Texas. This backing is a testament to the potential impact of the B-Series on the future of cancer diagnosis and management, although it's important to note that this product is currently not available for sale in the United States.

Perimeter’s involvement in the event aligns with its mission to transform cancer surgery through advanced imaging solutions that address significant unmet medical needs. The company's name, “PINK,” symbolizes its commitment to breast cancer awareness, further highlighting its focus on improving outcomes for patients battling this disease.

The showcase will provide attendees with the chance to partake in one-on-one investor meetings with Perimeter's management team, an excellent opportunity for investors to gain a deeper understanding of the company's vision and innovative technologies. Interested participants can register for the event and secure their meetings by following the registration link provided by the company.

Throughout the conference, attendees can expect engaging discussions around cutting-edge technologies and the evolving landscape of cancer treatment. Perimeter's commitment to innovation and excellence in imaging continues to set the standard as it strives to make significant contributions to the healthcare sector.

As the event approaches, excitement builds around what Perimeter will reveal about its plans for growth and how it aims to impact the cancer treatment community positively. For more information and to stay updated on the developments at the Planet MicroCap Showcase, visit Perimeter's official website where a live and archived version of Mendes’s presentation will be available for viewing.

About Perimeter Medical Imaging AI, Inc.

Established in both Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI is revolutionizing cancer surgeries with state-of-the-art imaging technology. The company’s focus remains on providing real-time, high-definition imaging to enhance the surgical process and improve patient outcomes. With a dedication to innovation and a supportive framework built through grants and partnerships, Perimeter is poised to lead advancements in cancer care.